Surfactant abnormalities in infants with severe viral bronchiolitis

Archives of Disease in Childhood

Volumn 75, Issue 2, 1996, Pages 133-136

  Dargaville, Peter A ^a,b   South, Michael ^c   McDougall, Peter N ^a,b  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b Department of Neonatology ^*  (Australia)

^c University Department of Pediatrics

Author keywords

Airway obstruction; Bronchiolitis; Pulmonary surfactants; Viral

Indexed keywords

PHOSPHATIDYLCHOLINE; SURFACTANT;

AIRWAY OBSTRUCTION; ARTICLE; BRONCHIOLITIS; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; INFANT; LUNG LAVAGE; PRIORITY JOURNAL; PROTEIN DEFICIENCY; VIRUS INFECTION;

EID: 0029813933     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.75.2.133     Document Type: Article

References (19)

1. Reynolds EOR, Cooke CD. The treatment of bronchiolitis. J Pediatr 1963; 63: 1205-7.
2. Rakshi K, Couriel JM. Management of acute bronchiolitis. Arch Dis Child 1994; 71: 463-9.
3. Hall CB. Respiratory syncytial virus. In: Feigin RD, Cherry JD, eds. Textbook of pediatric infectious diseases. 3rd Ed. Philadelphia: Saunders, 1992:1633-56.
4. Miller RR. Viral infections of the respiratory tract. In: Thurlbeck WM, ed. Pathology of the lung. New York: Thieme, 1988:157-9.
5. Gil J, Weibel ER. Extracellular lining of bronchioles after perfusion-fixation of rat lungs for electron microscopy. Anat Rec 1971; 169: 185-200.
6. Auten RL, Watkins RH, Shapiro DL, Horowitz S. Surfactant apoprotein A (SP-A) is synthesized in airway cells. Am J Respir Cell Mol Biol 1990; 3: 491-6.
7. Walker SR, Williams MC, Benson B. Immunocytochemical localization of the major surfactant apoproteins in type II cells, Clara cells, and alveolar macrophages of rat lung. Journal of Histochemistry and Cytochemistry 1986; 34:1137-48.
8. Halpern D, Grotberg JB. Surfactant effects on fluid-elastic instabilities of liquid-lined flexible tubes: a model of airway closure. Journal of Biomechanical Engineering 1993; 115: 271-7.
9. Mason RJ, Nellenbogen J, Clements JA. Isolation of disaturated phosphatidylcholine with osmium tetroxide. J Lipid Res 1976; 17: 281-4.
10. Kuroki Y, Takahashi H, Fukada Y. Two-site 'simultaneous' immunoassay with monoclonal antibodies for the determination of surfactant apoproteins in human amniotic fluid. Pediatr Res 1985; 19: 1017-20.
11. Rennard SI, Basset G, Lecossier D, et al. Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution. J Appl Physiol 1986; 60: 532-8.
12. Enhorning G. Pulsating bubble technique for evaluation pulmonary surfactant. J Appl Physiol 1977; 43: 198-203.
13. Hallman M, Merritt TA, Akino T, Bry K. Surfactant protein A, phosphatidylcholine, and surfactant inhibitors in epithelial lining fluid. Am Rev Respir Dis 1991; 144: 1376-84.
14. Bui KC, Walther FJ, David-Cu R, Garg M, Warburton D. Phospholipid and surfactant protein A concentrations in tracheal aspirates from infants requiring extracorporeal membrane oxygenation. J Pediatr 1992; 121: 271-4.
15. Venkitaraman AR, Baatz JE, Whitsett JA, Hall SB, Notter RH. Biophysical inhibition of synthetic phospholipid-lung surfactant apoprotein admixtures by plasma proteins. Chem Phys Lipids 1991; 57: 49-57.
16. Cockshutt AM, Weitz J, Possmayer F Pulmonary surfactant-associated protein A enhances the surface activity of lipid extract surfactant and reverses inhibition by blood proteins in vitro. Biochemistry 1990; 29: 8424-9.
17. Enhorning G, Holm BA. Disruption of pulmonary surfactant's ability to maintain openness of a narrow tube. J Appl Physiol 1993; 74: 2922-7.
18. Enhorning G, Duffy LC, Welliver RC. Pulmonary surfactant maintains patency of conducting airways in the rat. Am J Respir Crit Care Med 1995; 151: 554-6.
19. Rubin BK, Ramirez O, King M. Mucus rheology and transport in neonatal respiratory distress syndrome and the effect of surfactant therapy. Chest 1992; 101: 1080-5.